- Home
- CPAC vs LXRX Comparison
CPAC vs LXRX Comparison
Compare CPAC & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- LXRX
- Stock Information
- Founded
- CPAC 1949
- LXRX 1995
- Country
- CPAC Peru
- LXRX United States
- Employees
- CPAC N/A
- LXRX 103
- Industry
- CPAC Building Materials
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CPAC Industrials
- LXRX Health Care
- Exchange
- CPAC Nasdaq
- LXRX Nasdaq
- Market Cap
- CPAC 580.5M
- LXRX 541.5M
- IPO Year
- CPAC 2012
- LXRX 2000
- Fundamental
- Price
- CPAC $7.29
- LXRX $1.43
- Analyst Decision
- CPAC Sell
- LXRX Buy
- Analyst Count
- CPAC 2
- LXRX 5
- Target Price
- CPAC $6.95
- LXRX $3.23
- AVG Volume (30 Days)
- CPAC 19.0K
- LXRX 2.2M
- Earning Date
- CPAC 10-28-2025
- LXRX 11-06-2025
- Dividend Yield
- CPAC 6.89%
- LXRX N/A
- EPS Growth
- CPAC 20.27
- LXRX N/A
- EPS
- CPAC 0.15
- LXRX N/A
- Revenue
- CPAC $601,081,883.00
- LXRX $70,864,000.00
- Revenue This Year
- CPAC $9.96
- LXRX $66.55
- Revenue Next Year
- CPAC $1.70
- LXRX N/A
- P/E Ratio
- CPAC $9.59
- LXRX N/A
- Revenue Growth
- CPAC 6.18
- LXRX 1255.21
- 52 Week Low
- CPAC $5.10
- LXRX $0.28
- 52 Week High
- CPAC $7.57
- LXRX $1.66
- Technical
- Relative Strength Index (RSI)
- CPAC 52.78
- LXRX 51.65
- Support Level
- CPAC $7.16
- LXRX $1.36
- Resistance Level
- CPAC $7.40
- LXRX $1.64
- Average True Range (ATR)
- CPAC 0.19
- LXRX 0.12
- MACD
- CPAC -0.02
- LXRX 0.01
- Stochastic Oscillator
- CPAC 29.88
- LXRX 55.43
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.